Preview

Cardiovascular Therapy and Prevention

Advanced search

Pharmaceutical and non-pharmaceutical antihypertensive therapy in Type 2 diabetes mellitus patients

Abstract

Aim. To study ahtihypertensive therapy effects on carbohydrate metabolism in patients with arterial hypertension (AH) and Type 2 diabetes mellitus (DM-2). Material and methods. In total, 84 AH and DM-2 patients were examined: males and females aged 45-78 years (mean age 62.56±15.44 years). General physical examination, anthropometry, body mass index (BMI) calculation, blood pressure (BP), heart rate measurement, electrocardiography, general blood and urine assays, glucose tolerance test were performed; lipid profile, glycemia, fasting insulin, creatinine levels were measured. Results. In all participants, systolic and diastolic BP (SBP, DBP) levels decreased (p=0.001; p=0.001, respectively). Six months later, in Group I (BMI<30) mean SBP decreased from 160.9 to 145 mm Hg; mean DBP – from 94.8 to 86.8 mm Hg. In Group II (BMI 30-35) these figures were 160.8 to 144.5 mm Hg, and 97.3 to 88 mm Hg, respectively. In Group III (BMI>35), they were 167.9 to 148.9 mm Hg, and 99.8 to 87.6 mm Hg, respectively. In all three groups, glucose and cholesterol dynamics was not significant. Conclusion. In DM-2 patients receiving hypoglycemic agents, antihypertensive therapy did not affect carbohydrate metabolism. Significant cholesterol level decrease was observed in patients on strict fat-free and low-carbohydrate diet.

About the Author

S. G. Malishevsky
Kazan State Medical University. Kazan
Russian Federation


References

1. Bartol T. Diabetes Updates. Programs and abstracts of the National Conference for Nurse Practitioners; 2002 November 3- 6; Nashville, Tennessee. Sessions 305, 317, 406.

2. Misbin RI. Beneficial effects of a mild exercise programme on hypertriglyceridaemia, glucose tolerance and hyperinsulinaemia in obese patients [letter] SO. Diabetologia 1983; 25(4): 375.

3. Wysocki J, Belowski D, Kalina M, et al. Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome. Int J Clin Pharmacol Ther 2004; 42(4): 212-7.

4. Willerson JT, Jay NC. Cardiovascular medicine, second ed. 2000; 1498, 1523.

5. Batey DM, Kaufmann PG, Raczynski JM, et al. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I). SO - Ann Epidemiol 2000; 10(1): 45-58.

6. Wassertheil-Smoller S, Blaufox MD, Oberman AS, et al. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. J Arch Intern Med 1992; 152(1): 131-6.

7. Ganguli MC, Grimm RH Jr, Svendsen KH, et al. Higher education and income are related to a better Na:K ratio in blacks: baseline results of the Treatment of Mild Hypertension Study (TOMHS) data. SO - Am J Hypertens 1997; 10(9 Pt 1): 979-84.

8. Stsessen J, Fagard R, Lijnen R, Amery A. Body weight, sodium intake and blood pressure. J Hypertens 1989; 7(Suppl. 1): S19-23.

9. Basile J, Johnson RH. VA Medical Center, and the Medical University of South Carolina, Charleston, SC. Analysis of Recent Papers in Hypertension. J Clin Hypertens 2001; 3(1): 54-9.

10. Hunsicker LEJ, Pain LG, Ronde RP. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-8.

11. Kopelman PG. The effects of weight loss treatments on upper and lower body fat. J Obesity 1997; 21(8): 619-73.

12. Weidmann P, Uehlinger DE, Gerber A. Antihypertensive treatment and serum lipoproteins. J Hypertens 1985; 3(4): 297-306.


Review

For citations:


Malishevsky S.G. Pharmaceutical and non-pharmaceutical antihypertensive therapy in Type 2 diabetes mellitus patients. Cardiovascular Therapy and Prevention. 2006;5(2):46-49. (In Russ.)

Views: 1281


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)